Compounds > n-(2-hydroxypropyl)methacrylamide
Page last updated: 2024-08-23

n-(2-hydroxypropyl)methacrylamide and Lymphoma, T-Cell

n-(2-hydroxypropyl)methacrylamide has been researched along with Lymphoma, T-Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibrahimova, M; Rihova, B; Studenovsky, M; Ulbrich, K1
Etrych, T; Kostka, L; Kostková, H; Kovář, M; Ríhová, B; Starovoytová, L; Ulbrich, K1
Etrych, T; Kabesová, M; Kovár, L; Ríhová, B; Strohalm, J; Ulbrich, K1
Benda, A; Etrych, T; Hovorka, O; Kovár, L; Kovár, M; Ríhová, B; Sírová, M; Ulbrich, K1
Chytil, P; Etrych, T; Říhová, B; Strohalm, J; Ulbrich, K1

Other Studies

5 other study(ies) available for n-(2-hydroxypropyl)methacrylamide and Lymphoma, T-Cell

ArticleYear
Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2011, Jan-18, Volume: 42, Issue:1-2

    Topics: Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Female; Humans; Lymphoma, T-Cell; Mice; Molecular Structure; Polymethacrylic Acids; Pyrroles; Solubility; Xenograft Model Antitumor Assays

2011
HPMA copolymer conjugates of DOX and mitomycin C for combination therapy: physicochemical characterization, cytotoxic effects, combination index analysis, and anti-tumor efficacy.
    Macromolecular bioscience, 2013, Volume: 13, Issue:12

    Topics: Acrylamides; Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Lewis Lung; Cell Line, Tumor; Cytotoxins; Disulfides; Doxorubicin; Drug Carriers; Drug Therapy, Combination; Female; Kinetics; Levulinic Acids; Lymphoma, B-Cell; Lymphoma, T-Cell; Mammary Glands, Animal; Mice; Mice, Inbred C57BL; Mitomycin; Neoplasm Transplantation; Survival Analysis; Tumor Burden

2013
HPMA copolymer conjugates with reduced anti-CD20 antibody for cell-specific drug targeting. I. Synthesis and in vitro evaluation of binding efficacy and cytostatic activity.
    Journal of controlled release : official journal of the Controlled Release Society, 2009, Nov-16, Volume: 140, Issue:1

    Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Burkitt Lymphoma; Cell Line, Tumor; Cytostatic Agents; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Humans; Hydrogen-Ion Concentration; Lymphoma, T-Cell; Male; Methacrylates; Mice; Models, Chemical; Molecular Weight; Polymers; Solubility; Water

2009
Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond.
    Molecular pharmaceutics, 2010, Aug-02, Volume: 7, Issue:4

    Topics: Acrylamides; Amides; Animals; Antibiotics, Antineoplastic; Cell Line; Cell Line, Tumor; Doxorubicin; Humans; Hydrazones; Lymphoma, T-Cell; Mice; Mice, Inbred C57BL; Mice, Nude; Microscopy, Fluorescence; Molecular Structure; Polymers

2010
Novel star HPMA-based polymer conjugates for passive targeting to solid tumors.
    Journal of drug targeting, 2011, Volume: 19, Issue:10

    Topics: Acrylamides; Animals; Antibiotics, Antineoplastic; Delayed-Action Preparations; Dendrimers; Doxorubicin; Drug Carriers; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Lymphoma, T-Cell; Male; Mice; Mice, Inbred C57BL; Solubility; Tissue Distribution; Water

2011